India Glycols Limited — PPTs, 11-08-2025: Investor Presentation

Here is the summary based on your preferences:

**1. Financial Highlights:**

Q1 FY26 saw strong performance: Net Revenue up 7% to ₹ 1,040 Cr. EBITDA surged 18% to ₹ 151 Cr, with margins expanding to 14.5%. Profit After Tax (PAT) rose 21% to ₹ 73 Cr. Potable Spirits and Bio-Fuel segments primarily drove this growth.

**2. Strategic Initiatives & Growth Drivers:**

A proposed demerger will separate IGL into three focused entities: IGL, IGL Spirits Limited (ISL), and Ennature Bio Pharma Limited (EBL). This aims to unlock value and optimize capital. Capacity expansions are underway in Performance Chemicals and Bio-Fuel to meet rising demand.

**3. Business Developments:**

The Amrut partnership is gaining traction, extending to "Prestige Whisky." "Bunty Bubli" is recognized as India's highest-selling Country Liquor brand. IGL is also the first globally to commercialize bio-based amines and plans a stock split.

**4. Market Position & Competitive Advantage:**

IGL maintains a leadership position in branded Country Liquor in UP & UK. The company differentiates itself as a leading Green Chemical firm, pioneering bio-ethylene glycols from bio-ethanol. Integrated facilities and flexible ethanol sourcing enhance its competitive edge.

**5. Investor Implications:**

Robust Q1 financials suggest positive growth potential. The planned demerger aims to unlock shareholder value through focused businesses. Ongoing expansions and product innovations in green chemicals and bio-fuels indicate continued opportunities.